Related Experiment Video

Updated: Jul 9, 2026

Biochemical Measurement of Neonatal Hypoxia
13:13

Biochemical Measurement of Neonatal Hypoxia

Published on: August 24, 2011

Primary hyperoxaluria in infants: medical, ethical, and economic issues

P Cochat1, P C Koch Nogueira, M A Mahmoud

  • 1Département de Pédiatrie, Université Claude Bernard, Lyon, France.

The Journal of Pediatrics
|December 10, 1999
PubMed

Insights

Primary hyperoxaluria type 1 in infants presents significant ethical and financial challenges. Therapeutic withdrawal may be considered due to the severe nature of this rare genetic disorder.

Area of Science:

  • Pediatrics
  • Genetics
  • Metabolic Disorders

Background:

  • Primary hyperoxaluria type 1 (PH1) is a rare, inherited metabolic disorder.
  • It leads to oxalate accumulation, causing severe kidney damage and systemic oxalosis.
  • Early-onset PH1 poses significant challenges in diagnosis and management.

Purpose of the Study:

  • To survey the current medical approach to infants with PH1.
  • To investigate the economic issues affecting the management of infants with PH1.
  • To highlight the challenges in diagnosing and treating this rare condition.

Main Methods:

  • A global questionnaire was distributed to specialized centers.
  • Data were collected on 78 infants diagnosed with PH1.
  • Infants were categorized based on treatment location (developing vs. developed countries).

Main Results:

  • High consanguinity rates (76%) were observed in affected infants.
  • Common presentations included failure to thrive, UTIs, and uremia.
  • Diagnosis relied on family history, biopsy, and genetic analysis, varying by region.
  • Therapeutic withdrawal was used in 40% of cases, often due to financial reasons in developing countries.
  • End-stage renal disease and mortality were significantly higher in developing countries.
  • Transplantation outcomes were poorer in the absence of comprehensive care.

Conclusions:

  • Infant PH1 management exemplifies ethical, epidemiological, technical, and financial challenges of rare recessive diseases.
  • Oxalosis management requires a multidisciplinary approach.
  • Therapeutic withdrawal can be an acceptable option in specific challenging circumstances.
Abstract

More Related Videos

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents09:28

Oxygen-Induced Retinopathy Model for Ischemic Retinal Diseases in Rodents

Published on: September 16, 2020

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis07:45

Estimation of Urinary Nanocrystals in Humans using Calcium Fluorophore Labeling and Nanoparticle Tracking Analysis

Published on: February 9, 2021

Related Concept Videos

Ethical Issues01:27

Ethical Issues

Nurses are essential in patient care, upholding the ethical principles of their profession and effectively navigating ethical dilemmas. Neglecting ethical issues can lead to inadequate patient care, compromised therapeutic relationships, and moral distress among healthcare workers.
Ethical Concerns in Healthcare:
Ethical Dilemmas I01:17

Ethical Dilemmas I

Ethical dilemmas in nursing are of utmost importance, as they often arise from the tension between adhering to core ethical principles and the practical realities of healthcare delivery. These dilemmas require nurses to navigate complex situations where competing ethical considerations pull them in different directions.
Let us explore some examples to understand the potentially complex moral decisions nurses face.
Take the case of caring for minors, particularly in areas related to reproductive...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...